AASLD (American Association of Liver Diseases) 2024 was held in San Diego from November 15th (Friday) to November 19th (Tuesday), 2024. Lecturer Kota Tsuruta gave a presentation on two topics, "Impact of lipophilicity and daily dose on drug-induced liver injury in the Japanese cohort" and "Pemafibrate improves liver function with alteration of bile acid composition in patients with steatotic liver disease", and Assistant Professor Yusuke Mishima gave a presentation on "Liver-specific FXR deletion with human-like bile acid composition mice by in vivo gene editing using adeno-associated virus and CRISPR/Cas9 System". The discussions were lively, making it a very meaningful conference to attend.
Comments